Concurrent use of multiple NSAIDs increases the risk of gastrointestinal bleeding and kidney injury without providing additional analgesic benefit. It is generally advised to avoid combining diclofenac with other NSAIDs unless a specialist explicitly recommends it.
Diclofenac can trigger bronchospasm in a small subset of patients with aspirin-sensitive asthma. Those with a known NSAID-induced asthma flare should avoid Voltarol and discuss alternative analgesics with their clinician.
Taking the tablet with food or a full glass of water can reduce irritation. If symptoms persist, contact your healthcare provider, who may suggest a proton-pump inhibitor or an alternative pain medication.
Brand-name Voltarol tablets are typically white, round, and imprinted with “VOL 100”. Generic diclofenac tablets may vary in colour, shape, and imprint depending on the manufacturer, but the strength (100 mg) remains the same.
Diclofenac is not a controlled substance and is not screened for in standard workplace drug testing panels. However, some occupational health programs may request a full medication list for safety assessments.
Short courses (≤ 7 days) of diclofenac at recommended doses are generally safe for people with normal kidney function. Individuals with pre-existing renal disease should be monitored closely, even for brief therapy.
Both are NSAIDs, but diclofenac (Voltarol) is often considered more potent on a per-milligram basis for inflammatory joint conditions. Individual response varies, and side-effect profiles differ; a clinician can help determine the most suitable option.
Yes, provided you carry the medication in its original packaging with a prescription label. Some countries require a doctor’s note for NSAIDs, so check the destination’s import regulations before travel.
Typical excipients include lactose, microcrystalline cellulose, and magnesium stearate. Patients with specific allergies (e.g., lactose intolerance) should verify the exact formulation with their pharmacist.
Diclofenac can slightly elevate liver enzymes (ALT, AST) and may affect renal function markers (creatinine). If you are undergoing routine blood work, inform the laboratory or your physician about recent NSAID use.
Voltarol is a brand-name medication that contains the active ingredient diclofenac. It belongs to the pain-relief therapeutic class and is available in the United Kingdom as an oral pill of 100 mg strength. The product is prescription-only (POM) and is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).
Diclofenac is a non-steroidal anti-inflammatory drug (NSAID). It reduces pain and inflammation by inhibiting the cyclo-oxygenase (COX) enzymes, primarily COX-2, which are needed to produce prostaglandins-chemicals that promote inflammation, fever, and pain. By lowering prostaglandin levels, diclofenac decreases the sensation of pain and limits swelling at the site of injury.
Diclofenac is well absorbed from the gastrointestinal tract, with an oral bioavailability of about 50 %. It is extensively bound to plasma proteins (≈99 %) and is metabolised in the liver, mainly via CYP2C9, before being excreted in the urine.
In the UK, diclofenac tablets such as Voltarol are licensed for short-term relief of:
The medication is intended for adult patients who require additional pain control beyond simple analgesics like paracetamol.
Patients should always provide a complete medication list to their prescriber before starting Voltarol.
Standard dosing (based on the 100 mg tablet):
Special population adjustments
Administration tips
Missed dose: If you forget a dose, take it as soon as you remember unless it is near the time of your next scheduled dose. Do not double up.
Overdose: Symptoms may include severe nausea, vomiting, abdominal pain, and dizziness. Seek emergency medical help immediately; treatment is supportive and may involve activated charcoal.
Discontinuation: Abrupt stopping is generally safe, but if you have been using high doses for an extended period, discuss a tapering plan with your prescriber to minimise rebound pain.
Patients should contact their healthcare provider if they experience persistent stomach pain, unexplained swelling, sudden weight gain, or signs of bleeding.
This article provides educational information about Voltarol and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
